Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Norris Medicines Ltd (NSE: NORRIS), ISIN INE744C01029 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NORRIS last traded at ₹19.67 (-0.10%), with a 52-week range of ₹12.00 to ₹19.71 (as of 23 Sep 2026).
Shareholding as of Dec 2025: promoters 34.00%, FIIs 0.00%, DIIs 0.07%, mutual funds 0.01%.
EquiSense Score (ECS): 20/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.